Functional Characterization of Glucocorticoid Receptor Variants Is Required to Avoid Misinterpretation of NGS Data
Authors:
Open Access
- 6 March 2019
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 3 (5) , 865-881
Abstract
Recent advances in genetic analysis technologies such as Next Generation Sequencing (NGS), has considerably increased the incidental discovery of genetic abnormalities. Six heterozygous missense mutations of the human glucocorticoid receptor, hGR (encoded by the NR3C1 gene), have been identified in the context of genetic screening of endocrine pathologies. GR, a nuclear receptor, hormone-induced transcription factor, is involved in many physiological processes. Nevertheless, the pathogenic significance of incidentally discovered mutations remains obscure. The aim of this work was to characterize these new variants evaluating their functional impact on GR signaling. Six original GR variants, located in exon 2, lead to amino acid substitutions of the N-terminal domain of GR (F65V, M86V, A229T, A304E, N374S, R386Q), mainly excluding the activation function τ1 domain, potential site of functional interaction with transcriptional coregulators. Transient co-transfection in HEK293T cells of mutated GR expressing vectors and a luciferase reporter establishes dose-response curves for dexamethasone. This excluded any major transactivation abnormality of the mutated GRs (EC50 ≈ 0.2nM), identical maximal transactivation capacity than that of the wild-type (WT GR), without modification of the potentiation of transcriptional coactivator SRC2, except N374S. Moreover, protein expression of mutated GRs and their cytonuclear translocation studied by immunocytochemistry were almost unchanged as compared to WT GR. These results underline the silent nature of these missense GR variants and call for a cautious interpretation of the discovery of genetic incidentalomas by NGS in the absence of detailed characterization to appropriately assess their functional impact on a particular signaling pathway.Keywords
Funding Information
- Université Paris-Sud
- Inserm
This publication has 47 references indexed in Scilit:
- Folding of the glucocorticoid receptor N-terminal transactivation function: Dynamics and regulationMolecular and Cellular Endocrinology, 2012
- Novel genomic techniques open new avenues in the analysis of monogenic disordersHuman Mutation, 2011
- Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation SequencingScience Translational Medicine, 2011
- Familial Glucocorticoid Receptor Haploinsufficiency by Non-Sense Mediated mRNA Decay, Adrenal Hyperplasia and Apparent Mineralocorticoid ExcessPLOS ONE, 2010
- A Novel Point Mutation in the Amino Terminal Domain of the Human Glucocorticoid Receptor (hGR) Gene Enhancing hGR-Mediated Gene ExpressionThe Journal of Clinical Endocrinology & Metabolism, 2008
- Optimizing the protein switch: Altering nuclear import and export signals, and ligand binding domainJournal of Controlled Release, 2007
- Amino-Terminal Domain of TIF2 Is Involved in Competing for Corepressor Binding to Glucocorticoid and Progesterone ReceptorsBiochemistry, 2007
- Structure and function of steroid receptor AF1 transactivation domains: induction of active conformationsBiochemical Journal, 2005
- Recruitment of the SWI-SNF Chromatin Remodeling Complex as a Mechanism of Gene Activation by the Glucocorticoid Receptor τ1 Activation DomainMolecular and Cellular Biology, 2000
- Functional domains of the human glucocorticoid receptorCell, 1986